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Make it new: reformism and British public health
Plans are in place to replace Public Health England (PHE) 
with a National Institute of Health Protection (NIHP), 
which will be partly modelled on Germany’s Robert Koch 
Institute (RKI).
After months of headlines, the political temptation 
to remodel PHE is unsurprising. The question is, will this 
make things better? Considering recent decades and 
the very different ways in which public health works 
in other countries should make us cautious. Ad hoc 
reforms and systems transplantations rarely work. Each 
national public health system is unique and has evolved 
over decades to suit the specific country’s health system, 
constitutional structure, and politics. Effective reforms 
cost money and take time to bear fruit; they also tend 
to result in a phase of low staff morale and a loss of 
expertise, which we can ill afford during a pandemic.
Britain is a good example of the fallout of 
overambitious reformism. Between 1939 and 2003, 
the internationally renowned ancestor of PHE, the 
Public Health Laboratory Service (PHLS), presided over 
an integrated network, which at its height consisted 
of 69 local, regional, and national laboratories. The 
PHLS network enabled it to work effectively with 
local and National Health Service (NHS) authorities, 
respond flexibly to outbreaks, and bundle and analyse 
information at its Colindale headquarters. Autonomy 
also allowed the PHLS to act as an effective advocate for 
public health interests in Westminster and the NHS.
Having survived post-1970s budget cuts and market 
experiments, the PHLS was abolished as part of the Labour 
Government’s wider health reforms in 2003. The Health 
Protection Agency (HPA) was established to integrate 
forms of health protection, ranging from infectious 
disease to nuclear and chemical threats. In a blow to 
surveillance capability, the HPA lab network shrunk to 
eight regional hubs in addition to the Colindale campus. 
The remainder of the PHLS network was transferred to 
the NHS, despite warnings that individual trusts would 
have little incentive to maintain adequate funding once 
ring-fenced transition budgets ended in 2005. This 
move precipitated a loss of investment in laboratories, 
blurred responsibilities, and a weakening of public health 
integration between local and national levels.
Substantial budget and personnel cuts after 2008 
exacerbated problems. In 2013, the HPA was axed by 
the new Conservative government. The public health 
role of local government was strengthened and HPA 
infectious disease assets were integrated into PHE, a 
new Department of Health executive agency designed 
to pool data and coordinate responses. Visions of 
managerial efficiency contrasted with insufficient 
funding. The years between 2015 and 2020 saw 
substantial cuts to local government and PHE budgets, 
resulting in a public health system that was performing 
at a high level but running on fumes, a fact made 
painfully obvious by COVID-19.1
So how can British public health be reformed? Looking 
to Germany might not provide all the answers. Although 
the RKI was reformed with reference to the US Centers 
for Disease Control and Prevention and Colindale after 
1994, it is the child of a very different decentralised 
health system comprising federal, state, communal, and 
insurance-based services. During the first wave of the 
pandemic, the RKI was able to act as a coordinating hub 
for comparatively well funded local and state facilities, 
who were autonomous enough to react flexibly to 
local circumstances. German decision makers’ choice 
to incentivise—rather than outsource—testing by 
commercial operators via insurance reimbursements 
helped to boost capacity when it was needed. None of 
these goals are achievable in Britain without much wider 
health system reform.2
Rather than look abroad, Britain should focus on 
its own strengths. The PHLS was once a world leader 
in public health and PHE has outstanding scientists 
and clinicians. Reintegrating centralised surveillance 
with ground-level test and trace abilities could be an 
important first step to strengthening public health 
performance, but will need investment at all levels. 
Any reorganisation should also take account of the 
technological revolution involving testing and the 
way data is managed. We now expect test results in 
hours rather than days. This pace of change continues 
with the advent of high-throughput PCR and serology 
platforms capable of measuring hundreds of datapoints 
in thousands of samples per day. Running this so-called 
at pace model requires an integrated and immediately 
updatable platform to enable authorities to link personal 
data to test data in real time and to work closely with 
communities in the field. Building such an integrated 
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system requires a thought out ethical and community 
framework and investments throughout public health, 
including building a chain of specialised containment 
laboratories. 
In addition to sustained funding and new facilities, 
ministers should also have the courage to give NIHP 
enough autonomy to act as an effective lobby for public 
health within the wider health system in the UK. To do 
so, the new institute must be built on strong clinical and 
scientific leadership, which will entail picking a director 
with relevant expertise and resisting the urge to impose 
external shake ups every decade.
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